Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial

BACKGROUND: There are presently no available therapeutic options for peanut-allergic patients. OBJECTIVE: To investigate the safety, efficacy, and immunologic effects of peanut sublingual immunotherapy (SLIT). METHODS: After a baseline oral food challenge (OFC) of up to 2g of peanut powder (~50% pro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Fleischer, David M., Burks, A. Wesley, Vickery, Brian P., Scurlock, Amy M., Wood, Robert A., Jones, Stacie M., Sicherer, Scott H., Liu, Andrew H., Stablein, Donald, Henning, Alice K., Mayer, Lloyd, Lindblad, Robert, Plaut, Marshall, Sampson, Hugh A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3550002/
https://ncbi.nlm.nih.gov/pubmed/23265698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2012.11.011
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak